Marshall Wace »

Rani Therapeutics Hldgs shares owned by Marshall Wace

Quarter-by-quarter ownership of Rani Therapeutics Hldgs (RANI) shares owned by Marshall Wace from 13F filings

Historical chart of Marshall Wace investment in Rani Therapeutics Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Rani Therapeutics Hldgs held by Marshall Wace consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rani Therapeutics Hldgs by Marshall Wace

Quarter filed Position value Share count Share price at filing
2026-06-30 $446k 586k 0.76
2024-06-30 $81k 21k 3.80

More positions owned by Marshall Wace

Ishares-s&p 500 Equity Option Call Option (IVV)
Spdr Portfolio L Etp (SPYM)
Apple Common Stock (AAPL)
Adv Micro Device Common Stock (AMD)
Amazon.com Common Stock (AMZN)
Nvidia Corp Common Stock (NVDA)
Micron Tech Common Stock (MU)
Microsoft Corp Common Stock (MSFT)
Costco Wholesale Common Stock (COST)
Taiwan Semic- Adr (TSM)
Morgan Stanley Common Stock (MS)
Tesla Common Stock (TSLA)
Unitedhealth Grp Common Stock (UNH)
Alphabet Inc-a Common Stock (GOOGL)
Hilton Worldwide Common Stock (HLT)

View all positions for Marshall Wace

Top funds holding Rani Therapeutics Hldgs

RA Capital Management
Samsara BioCapital
AWM Investment Company
Vanguard Capital Management
SymBiosis Capital Partners
Longaeva Partners
Siren
Susquehanna International
Geode Capital Management
Marshall Wace
BlackRock
Nan Fung Group Holdings
683 Capital Management
Vanguard Fiduciary Trust
Renaissance Technologies

View all funds holding Rani Therapeutics Hldgs